Seres Therapeutics, Inc.

NASDAQ:MCRB

Biotechnology

Healthcare
$5.28 +1.70%

+$0.11 today

Market cap
$51.13M
Beta
0.11
P/E (TTM)
-1.3
EPS (TTM)
-$4.89
52W Low $5.31High $29.98

Volume 0.04M

Average 0.06M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$1.12M

FY 2025 · Annual

Investing Cash Flow

-$42,000.00

FY 2025 · Annual

Financing Cash Flow

$13.90M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(65.58M)(250.16M)(113.72M)136K5.7M
Depreciation & Amortization5.95M6.63M6.24M5.47M4.13M
Deferred Income Tax00000
Stock-Based Compensation20.22M25.48M34.1M20.97M10.84M
Change in Working Capital41.53M(18.39M)(58.98M)(65.51M)(27.78M)
Accounts Receivables9.39M0(8.67M)(2.07M)1.55M
Inventory00(29.65M)(33.8M)0
Accounts Payables9.36M2.2M(11.58M)(2.94M)(2.4M)
Other Working Capital22.78M(20.59M)(9.08M)(26.71M)(26.93M)
Other Non-Cash Items4.57M7.62M15M(109.68M)8.23M
Operating Cash Flow6.69M(228.82M)(117.35M)(148.61M)1.12M
Capital Expenditures(9.57M)(9.82M)(7.98M)(380K)(252K)
Acquisitions (Net)0(92.25M)00210K
Purchases of Investments(95.97M)(48.22M)(4.43M)13.52M0
Sales of Investments169.63M140.47M22.98M142.67M0
Other Investing Activities092.25M0(13.52M)0
Investing Cash Flow64.09M82.43M10.58M142.29M(42K)
Debt Repayment(948K)25.7M50.52M(127.91M)0
Common Stock Issued2.13M101.17M18.16M23.53M13.9M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.13M2.74M3.03M14M0
Financing Cash Flow1.18M129.6M71.71M(90.37M)13.9M
Effect of Forex Changes(1K)(1K)2K(1K)0
Net Change in Cash71.95M(16.79M)(35.07M)(96.69M)14.97M
Free Cash Flow(2.88M)(238.64M)(125.33M)(148.99M)865K

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$5.7M
+ D&A$4.1M
+ Stock-Based Comp$10.8M
+ Deferred Tax$0
- Working Capital-$27.8M
+ Other Non-Cash$8.2M
= Operating Cash Flow$1.1M
- Capex-$252.0K
= Free Cash Flow$865.0K

Analysis

FY2025 free cash flow is $865.0K. FCF conversion is 15.2% of net income. Operating cash flow was $1.1M, with capex of -$252.0K. The largest bridge item is Working Capital at -$27.8M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
EFFECTEFFECT filingAug 21, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026
4Statement of changes in beneficial ownershipAug 18, 2026

Does MCRB generate free cash flow?

Seres Therapeutics, Inc. (MCRB) generated $865,000.00 of free cash flow in fiscal 2025.

How much operating cash flow does MCRB produce?

Operating cash flow was $1.12M, before capital expenditures of $252,000.00.